Efficient HSA binding can facilitate targeted delivery, while strong DNA associations can enhance cytotoxic effects even in resistant cancer cells, making these interactions a focal point in developing more effective metallic anticancer agents [22,23,24]. This evidence concerns the gene ALB and cancer.